RETIVU
Live / Applied — Fourth extension granted (statement of use) (as of 20 Mar 2026)
What this means for you
Not registered yet, but its 20 Dec 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97724847
- Mark type
- Stylized text
- Filed
- 20 Dec 2022
- Published for opposition
- 31 Oct 2023
- Attorney of record
- Kimberly A Jarman
Goods and services
- Class 005 — Pharmaceuticals: Injectable pharmaceutical preparations for use by ophthalmologists, or other medical professionals qualified to administer ocular injections, for the treatment of eye diseases and conditions, excluding the treatment of cancer
Owner
- EYEPOINT US, INC., WATERTOWN, MA, US
- EyePoint Pharmaceuticals US, Inc., Watertown, MA, US
- EyePoint Pharmaceuticals US, Inc., Watertown, MA, US
Prosecution history
- 21 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Mar 2026 — SOU EXTENSION 4 GRANTED
- 20 Mar 2026 — SOU EXTENSION 4 FILED
- 20 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 11 Mar 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 02 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Oct 2025 — SOU EXTENSION 3 GRANTED
- 02 Oct 2025 — SOU EXTENSION 3 FILED
- 02 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 27 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Mar 2025 — SOU EXTENSION 2 GRANTED
- 26 Mar 2025 — SOU EXTENSION 2 FILED
- 26 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 02 Dec 2024 — REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
- 02 Dec 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED